Risk assessment of new psychoactive substances - EMCDDA - Europa

Risk assessment of new psychoactive substances: operating guidelinesby the General Secretariat of the Council to the EMCDDA referred to inparagraph 1.The Risk Assessment Report shall include:(a)(b)(c)(d)(e)(f)(g)(h)the physical and chemical description of the new psychoactive substance andits mechanisms of action, including its medical value;the health risks associated with the new psychoactive substance;the social risks associated with the new psychoactive substance;information on the level of involvement of organised crime and informationon seizures and/or detections by the authorities, and the manufacture of thenew psychoactive substance;information on any assessment of the new psychoactive substance in theUnited Nations system;where appropriate, a description of the control measures that are applicableto the new psychoactive substance in the Member States;options for control and the possible consequences of the control measures,andthe chemical precursors that are used for the manufacture of the substance.Article 7Circumstances where no risk assessment is carried out1. No risk assessment shall be carried out in the absence of a Europol/EMCDDAJoint Report. Nor shall a risk assessment be carried out where the newpsychoactive substance concerned is at an advanced stage of assessmentwithin the United Nations system, namely once the WHO expert committeeon drug dependence has published its critical review together with a writtenrecommendation, except where there is significant new information that isrelevant in the framework of this Decision.2. Where the new psychoactive substance has been assessed within the UnitedNations system, but it has been decided not to schedule the new psychoactivesubstance under the 1961 Single Convention on Narcotic Drugs or the 197184